<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02591589</url>
  </required_header>
  <id_info>
    <org_study_id>2014P000398</org_study_id>
    <nct_id>NCT02591589</nct_id>
  </id_info>
  <brief_title>Intraoperative Oxygen Concentration and Neurocognition After Cardiac Surgery</brief_title>
  <official_title>The Relationship Between Administered Oxygen Levels and Arterial Partial Oxygen Pressure to Neurocognition in Post-operative Mechanically Ventilated Cardiac Surgical Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, prospective controlled trial in patients undergoing cardiac surgery,
      specifically on-pump coronary artery bypass grafting, comparing level of administered oxygen
      and partial pressure of arterial oxygen in the operating room and its impact on a widely-used
      and validated neurocognitive score, the telephonic Montreal Cognitive Assessment (t-MoCA),
      throughout the hospital stay and at 1 month, 3 months, and 6 postoperatively. It is
      hypothesized that cardiac surgical patients who undergo normoxic conditions throughout the
      intraoperative period will have better neurocognitive function than those with maintenance of
      hyperoxia.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">November 1, 2019</completion_date>
  <primary_completion_date type="Actual">January 17, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Telephonic-MoCA (t-MoCA)</measure>
    <time_frame>Change from baseline tMoCA score through 6 months</time_frame>
    <description>t-MoCA will be performed baseline, daily starting POD#1 as well as at 1, 3 and 6 months post-operatively. In previous studies, testing through month 6, has been shown to accurately reflect more longitudinal follow-up. t-MoCA results are on a 22 point scale and will be used as a marker for cognitive function and has been validated. Blinded study staff trained in administering the assessments will collect the data.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Confusion Assessment Method for the ICU</measure>
    <time_frame>Post-operative day 1 through discharge from hospital (3-5 days on average)</time_frame>
    <description>CAM and CAM-ICU as a marker of delirium post-operatively will be administered and measured at the same time as the t-MoCA. This is a validated test to measure delirium. There is much data to support an increased reduction in cognitive ability in patients exhibiting post-operative delirium.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of mechanical ventilation</measure>
    <time_frame>Post-operative day 1 through discharge from hospital (3-5 days on average)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in hospital</measure>
    <time_frame>Post-operative day 1 through discharge from hospital (3-5 days on average)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to extubation</measure>
    <time_frame>Post-operative day 1 through discharge from hospital</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient mortality</measure>
    <time_frame>30 days and 6 months post-operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers of oxidative stress, IL-6, IL-8 and others</measure>
    <time_frame>Intraoperatively at cardiopulmonary bypass (CPB)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hyperoxia</condition>
  <condition>Normoxic</condition>
  <condition>Delirium</condition>
  <arm_group>
    <arm_group_label>Normoxic group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To standardize key aspects of ventilator support, tidal volume will be set to 6-8ml/kg and PEEP levels will be set to 0-5cm H2O, allowing flexibility for provider preference. For normoxic oxygenation FiO2 will be set at 0.35 (35%) ideally to maintain PaO2 above 70mmHg (or saturations greater than or equal to 92%), and titrated up if need be to prevent potentially injurious hypoxemia (saturations below 92%). During cardiopulmonary bypass, blended air/ oxygen mixture will be titrated to arterial blood gas analysis with maintenance of PaO2 between 100mmHg and 150mmHg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperoxic group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To standardize key aspects of ventilator support, tidal volume will be set to 6-8ml/kg and PEEP levels will be set to 0-5cm H2O, allowing flexibility for provider preference. For hyperoxic oxygenation FiO2 will be set at 1.0 (100%) throughout the intraoperative period, including cardiopulmonary bypass.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normoxic oxygenation</intervention_name>
    <description>FiO2 set at 0.35 to maintain PaO2 &gt; 70 mmHg or oxygen saturation greater than or equal to 92%.</description>
    <arm_group_label>Normoxic group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hyperoxic oxygenation</intervention_name>
    <description>FiO2 set at 1.0 throughout the procedure</description>
    <arm_group_label>Hyperoxic group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females aged 65 years and older

          -  Undergoing elective or urgent on-pump Coronary Artery Bypass Graft (CABG) only

        Exclusion Criteria:

          -  Off-pump or any other procedure in addition to CABG

          -  Emergent procedure

          -  One-lung ventilation

          -  Non-English speaking

          -  Baseline tMoCA score &lt;10

          -  Preoperative inotrope use

          -  Preoperative vasopressor use

          -  Intra-aortic balloon counterpulsation

          -  Mechanical circulatory support (Intra-aortic balloon pump (IABP)/ Ventricular assisted
             devices (VAD)/Extracorporeal membrane oxygenation (ECMO))

          -  Active cardiac ischemia

          -  Acute decompensated arrhythmia

          -  O2 sat &lt; 90% on supplemental oxygen

          -  Use of continuous vasopressor or inotrope infusion medications

          -  Significant physician or nurse concern

        Cessation Criteria

          -  Development of significant intraoperative hemodynamic compromise as a result of
             cardiac surgery

          -  Oxygen desaturation &lt;90% for &gt; 3 min

          -  Significant physician or nurse concern
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shahzad Shaefi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Kilgannon JH, Jones AE, Parrillo JE, Dellinger RP, Milcarek B, Hunter K, Shapiro NI, Trzeciak S; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Relationship between supranormal oxygen tension and outcome after resuscitation from cardiac arrest. Circulation. 2011 Jun 14;123(23):2717-22. doi: 10.1161/CIRCULATIONAHA.110.001016. Epub 2011 May 23.</citation>
    <PMID>21606393</PMID>
  </reference>
  <reference>
    <citation>Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, Parrillo JE, Trzeciak S; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA. 2010 Jun 2;303(21):2165-71. doi: 10.1001/jama.2010.707.</citation>
    <PMID>20516417</PMID>
  </reference>
  <reference>
    <citation>Bellomo R, Bailey M, Eastwood GM, Nichol A, Pilcher D, Hart GK, Reade MC, Egi M, Cooper DJ; Study of Oxygen in Critical Care (SOCC) Group. Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. Crit Care. 2011;15(2):R90. doi: 10.1186/cc10090. Epub 2011 Mar 8.</citation>
    <PMID>21385416</PMID>
  </reference>
  <reference>
    <citation>Trzeciak S, Jones AE, Kilgannon JH, Milcarek B, Hunter K, Shapiro NI, Hollenberg SM, Dellinger P, Parrillo JE. Significance of arterial hypotension after resuscitation from cardiac arrest. Crit Care Med. 2009 Nov;37(11):2895-903; quiz 2904.</citation>
    <PMID>19866506</PMID>
  </reference>
  <reference>
    <citation>Eastwood G, Bellomo R, Bailey M, Taori G, Pilcher D, Young P, Beasley R. Arterial oxygen tension and mortality in mechanically ventilated patients. Intensive Care Med. 2012 Jan;38(1):91-8. doi: 10.1007/s00134-011-2419-6. Epub 2011 Nov 30.</citation>
    <PMID>22127482</PMID>
  </reference>
  <reference>
    <citation>Pilcher J, Weatherall M, Shirtcliffe P, Bellomo R, Young P, Beasley R. The effect of hyperoxia following cardiac arrest - A systematic review and meta-analysis of animal trials. Resuscitation. 2012 Apr;83(4):417-22. doi: 10.1016/j.resuscitation.2011.12.021. Epub 2012 Jan 5. Review.</citation>
    <PMID>22226734</PMID>
  </reference>
  <reference>
    <citation>Neumar RW. Optimal oxygenation during and after cardiopulmonary resuscitation. Curr Opin Crit Care. 2011 Jun;17(3):236-40. doi: 10.1097/MCC.0b013e3283454c8c. Review.</citation>
    <PMID>21415737</PMID>
  </reference>
  <reference>
    <citation>Janz DR, Hollenbeck RD, Pollock JS, McPherson JA, Rice TW. Hyperoxia is associated with increased mortality in patients treated with mild therapeutic hypothermia after sudden cardiac arrest. Crit Care Med. 2012 Dec;40(12):3135-9. doi: 10.1097/CCM.0b013e3182656976.</citation>
    <PMID>22971589</PMID>
  </reference>
  <reference>
    <citation>O'Driscoll BR, Howard LS. How to assess the dangers of hyperoxemia: methodological issues. Crit Care. 2011;15(3):435; author reply 435. doi: 10.1186/cc10272. Epub 2011 Jun 30.</citation>
    <PMID>21722333</PMID>
  </reference>
  <reference>
    <citation>de Jonge E, Peelen L, Keijzers PJ, Joore H, de Lange D, van der Voort PH, Bosman RJ, de Waal RA, Wesselink R, de Keizer NF. Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients. Crit Care. 2008;12(6):R156. doi: 10.1186/cc7150. Epub 2008 Dec 10.</citation>
    <PMID>19077208</PMID>
  </reference>
  <reference>
    <citation>Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, Jones RN. Cognitive trajectories after postoperative delirium. N Engl J Med. 2012 Jul 5;367(1):30-9. doi: 10.1056/NEJMoa1112923.</citation>
    <PMID>22762316</PMID>
  </reference>
  <reference>
    <citation>Laffey JG, Talmor D. Predicting the development of acute respiratory distress syndrome: searching for the “Troponin of ARDS”. Am J Respir Crit Care Med. 2013 Apr 1;187(7):671-2.</citation>
    <PMID>23540873</PMID>
  </reference>
  <reference>
    <citation>Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA; Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001 Feb 8;344(6):395-402. Erratum in: N Engl J Med 2001 Jun 14;344(24):1876.</citation>
    <PMID>11172175</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2015</study_first_submitted>
  <study_first_submitted_qc>October 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2015</study_first_posted>
  <last_update_submitted>March 6, 2018</last_update_submitted>
  <last_update_submitted_qc>March 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beth Israel Deaconess Medical Center</investigator_affiliation>
    <investigator_full_name>Shahzad Shaefi</investigator_full_name>
    <investigator_title>Anesthesiologist</investigator_title>
  </responsible_party>
  <keyword>Hyperoxia</keyword>
  <keyword>Delirium</keyword>
  <keyword>Normoxic</keyword>
  <keyword>t-MoCA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Hyperoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

